General Information of the Compound
Compound ID
CP0162102
Compound Name
5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine
    Show/Hide
Synonyms
5''-(quinolin-4-yl)-2,4''-bithiazol-2''-amine
5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine
BDBM50151351
CHEMBL362710
    Show/Hide
Structure
Formula
C15H10N4S2
Molecular Weight
310.407
Canonical SMILES
Nc1nc(-c2nccs2)c(s1)-c1ccnc2ccccc12
    Show/Hide
InChI
InChI=1S/C15H10N4S2/c16-15-19-12(14-18-7-8-20-14)13(21-15)10-5-6-17-11-4-2-1-3-9(10)11/h1-8H,(H2,16,19)
    Show/Hide
InChIKey
JHZIIPPDVRVCNU-UHFFFAOYSA-N
Physicochemical Property
logP
4.064
Rotatable Bonds
2
Heavy Atom Count
21
Polar Areas
64.69
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
6
Complexity
21

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 11197671
SID: 16279343
ChEMBL ID
CHEMBL362710
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01221, TGF-beta receptor type-1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000063 Hep-G2 Homo sapiens (Human)  1
1
IC50 = 6580 nM
   TI
   LI
   LO
   TS
Biochemical Assays
1 IC50 = 1170 nM
2 IC50 = 1175 nM
Clinical Information about the Compound
Drug 1 ( 5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine )
Drug Name 5''-Quinolin-4-yl-[2,4'']bithiazolyl-2''-ylamine
Target(s)
TGF-beta receptor type I (TGFBR1)
Inhibitor